|Next | |Back | |Home |

Study Protocols

The study protocols and therapy regimens are regularly revised by the Study Group. Medication and dose recommendations given in this document should be used as guidelines. Correct application of any therapy to a patient is in the responsibility of the physician. The Study Group does not accept responsibility for any harm caused by the use of their therapy protocols.

  • Conventional Therapy
  • Primary Glomerulonephritis
  • General Information
  • Aim of the Study
  • Inclusion Criteria
  • Study Endpoint
  • Follow-up
  • Concomitant Therapy
  • Patient Consent
  • Minimal Change Glomerulonephritis
  • Focal-segmental Glomerulosclerosis
  • Membranous Glomerulonephritis
  • Membranoproliferative Glomerulonephritis
  • Mesangioproliferative Glomerulonephritis
  • IgA-Nephropathy
  • Rapidly progressive Glomerulonephritis
  • Secondary Glomerulonephritis
  • Experimental Therapy
  • Primary Glomerulonephritis
  • IgA-Nephropathy
  • Chronic Glomerulonephritis
  • Focal-segmental Glomerulosclerosis
  • Secondary Glomerulonephritis
  • General Information
  • Systemic Lupus erythematosus
  • |Next | |Back | |Home |


    © Copyright by CGTS 1995; last modified 28/12/95.